Table 4: Effect of KIR-HLA ligand matches/mismatches on graft survival among CMV infected renal transplant cases.

Table 4: Effect of KIR-HLA ligand matches/mismatches on graft survival among CMV infected renal transplant cases.

KIR	HLA			CMV		Non-CMV
KIR-HLA ligand match
		Chi-Square (X˛)	p-value	Mean Survival+SE (in months)	95%CI	Mean Survival+SE (in months)	95%CI
KIR2DL2	HLA-C1	1.21	0.211	32.00 ą 7.69	19.42-41.31	51.22 ą 1.12	46.89-59.91
KIR2DL3	HLA-C1	0.23	0.062	29.00 ą 5.23	21.21-42.52	49.73 ą 1.98	42.63-57.32
KIR2DS2	HLA-C1	0.78	0.321	38.50 ą 6.98	24.81-52.18	65.71 ą 2.25	61.28-70.14
KIR2DS3	HLA-C1	2.17	0.140	37.66 ą 8.61	20.77-54.55	65.83 ą 2.25	61.42-70.24
KIR2DL1	HLA-C2	3.45	0.013*	36.41 ą 7.59	36.41 ą 7.59	55.79 ą 2.21	51.45-60.14
KIR2DS1	HLA-C2	0.32	0.005*	40.16 ą 8.75	23.00-57.33	72.78 ą 2.42	68.03-77.53
KIR3DL1	HLA-Bw4	3.23	0.032*	36.00 ą 7.82	20.66-51.33	54.12 ą 2.09	50.01-58.23
KIR3DS1	HLA-Bw4	1.73	0.201	36.41 ą 7.84	21.04-51.78	59.80 ą 2.32	55.24-64.36

*= p< 0.05 & statistically significant.